These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 7699543)

  • 1. Changing trends in the epidemiology and pathogenesis of neonatal chronic lung disease.
    Rojas MA; Gonzalez A; Bancalari E; Claure N; Poole C; Silva-Neto G
    J Pediatr; 1995 Apr; 126(4):605-10. PubMed ID: 7699543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of infection on patent ductus arteriosus and chronic lung disease in premature infants weighing 1000 grams or less.
    Gonzalez A; Sosenko IR; Chandar J; Hummler H; Claure N; Bancalari E
    J Pediatr; 1996 Apr; 128(4):470-8. PubMed ID: 8618179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for chronic lung disease in the surfactant era: a North Carolina population-based study of very low birth weight infants. North Carolina Neonatologists Association.
    Marshall DD; Kotelchuck M; Young TE; Bose CL; Kruyer L; O'Shea TM
    Pediatrics; 1999 Dec; 104(6):1345-50. PubMed ID: 10585987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in the pathogenesis and prevention of chronic lung disease of prematurity.
    Bancalari E
    Am J Perinatol; 2001; 18(1):1-9. PubMed ID: 11321240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Failure of a repeat course of cyclooxygenase inhibitor to close a PDA is a risk factor for developing chronic lung disease in ELBW infants.
    Adrouche-Amrani L; Green RS; Gluck KM; Lin J
    BMC Pediatr; 2012 Jan; 12():10. PubMed ID: 22284694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ibuprofen for the treatment of a patent ductus arteriosus in preterm and/or low birth weight infants.
    Ohlsson A; Walia R; Shah S
    Cochrane Database Syst Rev; 2003; (2):CD003481. PubMed ID: 12804469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic lung disease in very low birthweight infants: a 5-year review.
    Yeo CL; Choo S; Ho LY
    J Paediatr Child Health; 1997 Apr; 33(2):102-6. PubMed ID: 9145350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patent ductus arteriosus in premature infants: to treat or not to treat?
    Mohamed MA; El-Dib M; Alqahtani S; Alyami K; Ibrahim AN; Aly H
    J Perinatol; 2017 Jun; 37(6):652-657. PubMed ID: 28206995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhaled versus systemic corticosteroids for preventing chronic lung disease in ventilated very low birth weight preterm neonates.
    Shah SS; Ohlsson A; Halliday H; Shah VS
    Cochrane Database Syst Rev; 2003; (1):CD002058. PubMed ID: 12535425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early introduction of lipids to parenterally-fed preterm infants.
    Simmer K; Rao SC
    Cochrane Database Syst Rev; 2005 Apr; (2):CD005256. PubMed ID: 15846747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bronchodilators for the prevention and treatment of chronic lung disease in preterm infants.
    Ng GY; da S; Ohlsson A
    Cochrane Database Syst Rev; 2001; (3):CD003214. PubMed ID: 11687053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low gestational age and chronic lung disease are synergistic risk factors for retinopathy of prematurity.
    Giapros V; Drougia A; Asproudis I; Theocharis P; Andronikou S
    Early Hum Dev; 2011 Oct; 87(10):653-7. PubMed ID: 21621351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cromolyn sodium for the prevention of chronic lung disease in preterm infants.
    Ng GY; Ohlsson A
    Cochrane Database Syst Rev; 2001; (2):CD003059. PubMed ID: 11406065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolonged versus short course of indomethacin for the treatment of patent ductus arteriosus in preterm infants.
    Herrera C; Holberton J; Davis P
    Cochrane Database Syst Rev; 2004; (1):CD003480. PubMed ID: 14974018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical characteristics of chronic lung disease without preceding respiratory distress syndrome in preterm infants.
    Choi CW; Kim BI; Koh YY; Choi JH; Choi JY
    Pediatr Int; 2005 Feb; 47(1):72-9. PubMed ID: 15693871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Respiratory outcomes study (RESPOS) for preterm infants at primary school age.
    Astle V; Broom M; Todd DA; Charles B; Ringland C; Ciszek K; Shadbolt B
    J Asthma; 2015 Feb; 52(1):40-5. PubMed ID: 25162302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chorioamnionitis, mechanical ventilation, and postnatal sepsis as modulators of chronic lung disease in preterm infants.
    Van Marter LJ; Dammann O; Allred EN; Leviton A; Pagano M; Moore M; Martin C;
    J Pediatr; 2002 Feb; 140(2):171-6. PubMed ID: 11865267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for the different types of chronic lung diseases of prematurity according to the preceding respiratory distress syndrome.
    Choi CW; Kim BI; Park JD; Koh YY; Choi JH; Choi JY
    Pediatr Int; 2005 Aug; 47(4):417-23. PubMed ID: 16091080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhaled versus systemic corticosteroids for the treatment of chronic lung disease in ventilated very low birth weight preterm infants.
    Shah SS; Ohlsson A; Halliday H; Shah VS
    Cochrane Database Syst Rev; 2003; (2):CD002057. PubMed ID: 12804423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early postnatal (<96 hours) corticosteroids for preventing chronic lung disease in preterm infants.
    Halliday HL; Ehrenkranz RA; Doyle LW
    Cochrane Database Syst Rev; 2003; (1):CD001146. PubMed ID: 12535402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.